Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system
Liraglutide vs Semaglutide: The Molecular Difference Liraglutide (Saxenda): First-generation GLP-1 agonist for weight loss Approximately 97% amino acid similarity to natural GLP-1 Half-life of approximately 13 hours Requires daily injection to maintain blood levels Semaglutide (Ozempic, Wegovy): Second-generation GLP-1 agonist Modified structure for greater potency and longer action Half-life of approximately 7 days Weekly injection maintains stable blood levels The structural modifications in semaglutide make it bind more effectively to GLP-1 receptors and resist breakdown longer
NEJM 2021 Rubino D et al
Zhao, H., Wang, L., Wei, R., Xiu, D., Tao, M., Ke, J., Liu, Y., Yang, J., & Hong, T